Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms

International Journal of Clinical Practice

Volumn 65, Issue 5, 2011, Pages 552-558

  Liao, C H ^a   Chung, S D ^b   Kuo, H C ^c,d  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL SENSATION; ADULT; AGED; ARTICLE; BLADDER DYSFUNCTION; BLADDER SPHINCTER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FAILURE TO STORAGE LOWER URINARY TRACT SYMPTOM; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MUSCLE CONTRACTILITY; NON INVASIVE MEASUREMENT; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE RELAXATION; URETHRA STRICTURE; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATISM; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX; URINARY INCONTINENCE; URINARY RETENTION; URINATION; URODYNAMICS;

EID: 79954458006     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02638.x     Document Type: Article

References (26)

1. Abrams P, Cardozo L, Fall M, et al., The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. (Pubitemid 34195211)
2. Chapple CR, Wein AJ, Abrams P, et al., Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol 2008; 54: 563-9.
3. Wein AJ,. Pathophysiology and categorization of voiding dysfunction. In:, Walsh PC, et al., eds. Campbell's Urology, 7th edn. Philadelphia, PA: WB Saunders, 1998: 917-26.
4. Wein AJ, Rackley RR,. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2006; 175 (3 Pt 2): S5-10. (Pubitemid 43177185)
5. Chapple CR, Roehrborn CG,. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006; 49: 651-8. (Pubitemid 43374725)
6. Ignjatovic I,. Symptoms and urodynamics after unsuccessful transurethral prostatectomy. Int Urol Nephrol 2001; 32: 655-8. (Pubitemid 34272330)
7. Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB,. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004; 94: 817-20. (Pubitemid 39472476)
8. Blake-James BT, Rashidian A, Ikeda Y, Emberton M,. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int 2007; 99: 85-96. (Pubitemid 44915626)
9. Madersbacher S, Pycha A, Klingler CH, Schatzl G, Marberger M,. The International Prostate Symptom score in both sexes: a urodynamics-based comparison. Neurourol Urodyn 1999; 18: 173-82. (Pubitemid 29235043)
10. Apostolidis A, Kirana PS, Chiu G, Link C, Tsiouprou M, Hatzichristou D,. Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the Hospitalised and Outpatients' Profile and Expectations Study. Eur Urol 2009; 56: 937-47.
11. Chen JL, Chen CY, Kuo HC,. Botulinum toxin A injection to the bladder neck and urethra for medically refractory lower urinary tract symptoms in men without prostatic obstruction. J Formos Med Assoc 2009; 108: 950-6.
12. Höfner K, Burkart M, Jacob G, Jonas U,. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol 2010; 28: 353-7.
13. de la Rosette JJ, Witjes WP, Schäfer W, et al., Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn 1998; 17: 99-108. (Pubitemid 28150529)
14. Cockett A, Aso Y, Denis L, et al., Recommendation of the International Consensus Committee concerning: 1. prostate symptom score and quality of life assessment. In:, Cockett ATK, Khoury S, eds. Proceedings, The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27-30, 1993. Jersey: Channel Island, Scientific Communication International Ltd, 1994: 553-5.
15. Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K,. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol 2008; 54: 419-26.
16. Haylen BT, de Ridder D, Freeman RM, et al., An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.
17. Chung SD, Chiu B, Kuo HC, et al., Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder. BJU Int 2010; 105: 668-72.
18. Kuo HC,. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology 2007; 70: 272-6.
19. de la Rosette JJ, Alivizators G, Madersbacher S, et al., EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001; 40: 256-64. (Pubitemid 34701895)
20. Steele GS, Sullivan MP, Sleep DJ, Yalla SV,. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol 2000; 164: 344-8. (Pubitemid 30481921)
21. Porru D, Jallous H, Cavalli V, Sallusto F, Rovereto B,. Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH. Eur Urol 2002; 41: 246-9. (Pubitemid 35303420)
22. Kuo HC,. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology 1999; 54: 90-6.
23. Van Venrooij GE, Eckhardt MD, Boon TA,. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Urology 2004; 63: 476-80.
24. Oelke M, Hofner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H,. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 2007; 52: 827-34.
25. Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA,. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 2007; 61: 1535-46. (Pubitemid 47228616)
26. AUA Practice Guideline Committee. AUA guidelines on the management of benign prostatic hyperplasia. Chapter 1. Diagnosis and treatment recommendations. J Urol 2003; 170 (2 Pt 1): 530-47.